NCT02596451: To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion). |
|
|
| Completed | 3 | 1164 | US | Diclofenac Sodium gel, 1%, Voltaren® Gel, Placebo | Glenmark Pharmaceuticals Ltd. India | Osteoarthritis | 03/16 | 03/16 | | |
2015-001779-29: Multicenter clinical trial to evaluate efficacy and safety of diclofenac 1% gel produced by Epifarma s.r.l. compared to Voltaren® Emulgel® 1% gel |
|
|
| Completed | 3 | 749 | Europe | Diclofenac 1% gel, Gel, Voltaren Emulgel® 1% gel | Epifarma s.r.l., Epifarma s.r.l. | Patients with acute painful and flogistic (inflammatory) disease due to acute traumatic events (injury/contusion) of joints, muscles, tendons and ligaments, Patients with injury/contusion of joints, muscles, tendons and ligaments, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2015-004102-42: Three group trial, to evaluate the non-inferiority, efficacy and safety of diclofenac 2% gel (Test) versus the originator diclofenac 2% gel chosen as Reference and superiority vs Placebo, in improving pain symptoms. |
|
|
| Completed | 3 | 749 | Europe | Diclofenac 2%, Voltaren Emulgel 2% gel, Diclofenac 2%, M02AA15, Gel, Voltaren Emulgel 2% Gel tubo da 60 g | Epifarma S.r.l., EPIFARMA S.R.L., Epifarma S.r.l., Epifarma srl | Acute traumatic events (injury/contusion) classified from mild to moderate pain at rest to the joints, muscles, tendons and ligaments, Acute traumatic events (injurt/contusions), Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
